<?xml version="1.0"?>
<Articles JournalTitle="Case Reports in Clinical Practice">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Case Reports in Clinical Practice</JournalTitle>
      <Issn>2538-2683</Issn>
      <Volume>3</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>17</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Anti-Glomerular Basement Membrane Disease With Thrombotic Thrombocytopenic Purpura</title>
    <FirstPage>106</FirstPage>
    <LastPage>112</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Amirhesam</FirstName>
        <LastName>Alirezaei</LastName>
        <affiliation locale="en_US">Clinical Research and Development Center, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Department of Nephrology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahmood</FirstName>
        <LastName>Bakhtiyari</LastName>
        <affiliation locale="en_US">Department of Community Medicine, Faculty of Medicine, Alborz University of Medical Sciences, Karaj, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Elham</FirstName>
        <LastName>Zare</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>08</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>11</Month>
        <Day>18</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">We report a 25-year-old man who was initially presented with Rapidly Progressive Glomerulonephritis (RPGN) in Shahid Modarress Hospital, Tehran, Iran. His diagnosis was Anti-Glomerular Basement Membrane (Anti-GBM) disease that was confirmed by kidney biopsy, as his serum Anti-GBM antibody was undetectable. Although the patient was on cyclophosphamide and high dose prednisolone, he developed Thrombotic Thrombocytopenic Purpura (TTP). We initiated treatment with a high dose of prednisone and plasmapheresis. Because of his poor response, rituximab was administered. After that, the patient&#x2019;s hematologic criteria and clinical symptoms improved to an acceptable level. Our case is a unique form of negative serum Anti-GBM antibody disease which was complicated with TTP&#xA0;and responded to treatment with rituximab</abstract>
    <web_url>https://crcp.tums.ac.ir/index.php/crcp/article/view/213</web_url>
    <pdf_url>https://crcp.tums.ac.ir/index.php/crcp/article/download/213/301</pdf_url>
  </Article>
</Articles>
